Suppr超能文献

波士顿角膜假体:结果和并发症:美国眼科学会的报告。

Boston Keratoprosthesis: Outcomes and Complications: A Report by the American Academy of Ophthalmology.

机构信息

Piedmont Hospital and Eye Consultants of Atlanta, Atlanta, Georgia.

Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan.

出版信息

Ophthalmology. 2015 Jul;122(7):1504-11. doi: 10.1016/j.ophtha.2015.03.025. Epub 2015 Apr 28.

Abstract

OBJECTIVE

To review the published literature on safety and outcomes of the Boston type I keratoprosthesis (BI-KPro) for the surgical treatment of corneal opacification not amenable to human cadaveric corneal transplantation.

METHODS

Searches of peer-reviewed literature were conducted in PubMed and the Cochrane Library in December 2012, July 2013, and January 2014 without date restrictions. The searches were limited to studies published in English and yielded 587 citations. The abstracts of these articles were reviewed, 48 articles were selected for possible clinical relevance, and 22 were determined to be relevant for the assessment objectives. Nine studies were rated as level II evidence and 13 studies were rated as level III evidence. Excluded were level III evidence, case reports, review articles, letters, editorials, and case series with fewer than 25 eyes.

RESULTS

In 9 articles, a best-corrected Snellen visual acuity (BCSVA) of 20/200 or better occurred in 45% to 89% of eyes. Five articles described a BCSVA of 20/50 or better in 43% to 69% of eyes, and 4 articles found a BCSVA of 20/40 or better in 11% to 39% of eyes. Retention rates of the BI-KPro ranged from 65% to 100%. Reasons for loss of vision after BI-KPro implantation most commonly included corneal melts resulting from exposure keratopathy, endophthalmitis, and infectious keratitis or corneal ulceration. The 2 most common complications after surgery were retroprosthetic membrane formation (range, 1.0%-65.0%; mean ± standard deviation [SD], 30.0±19.0%) and elevated intraocular pressure (range, 2.4%-64.0%; mean ± SD, 27.5±18.1%). The 2 most common posterior segment complications were endophthalmitis (range, 0%-12.5%; mean ± SD, 4.6±4.6%) and vitritis (range, 0%-14.5%; mean ± SD, 5.6±4.7%).

CONCLUSIONS

The reviewed articles on BI-KPro use suggest that the device improves vision in cases of severe corneal opacification that were not amenable to corneal transplantation using human cadaveric keratoplasty techniques. A number of severe anterior and posterior segment complications can develop as follow-up continues, making ongoing close observation paramount for patients undergoing this surgery. These complications include infection, device extrusion, and permanent vision loss.

摘要

目的

综述波士顿 I 型角膜假体(BI-KPro)治疗无法进行人尸体角膜移植的角膜混浊的安全性和结果的已发表文献。

方法

于 2012 年 12 月、2013 年 7 月和 2014 年 1 月在 PubMed 和 Cochrane 图书馆中进行了同行评议文献的检索,无时间限制。检索仅限于发表的英文研究,并产生了 587 条引文。审查了这些文章的摘要,选择了 48 篇可能具有临床相关性的文章,并确定了 22 篇文章与评估目标相关。9 项研究被评为 II 级证据,13 项研究被评为 III 级证据。排除了 III 级证据、病例报告、综述文章、信件、社论和少于 25 只眼的病例系列。

结果

在 9 篇文章中,45%至 89%的眼睛最佳矫正视力(BCSVA)达到 20/200 或更好。5 篇文章描述了 43%至 69%的眼睛 BCSVA 达到 20/50 或更好,4 篇文章发现 11%至 39%的眼睛 BCSVA 达到 20/40 或更好。BI-KPro 的保留率为 65%至 100%。BI-KPro 植入后视力丧失的原因最常见的包括暴露性角膜病导致的角膜融解、眼内炎和感染性角膜炎或角膜溃疡。术后最常见的两种并发症是后弹力膜形成(范围 1.0%至 65.0%;平均值±标准差[SD],30.0±19.0%)和眼内压升高(范围 2.4%至 64.0%;平均值±SD,27.5±18.1%)。最常见的两种后节并发症是眼内炎(范围 0%至 12.5%;平均值±SD,4.6±4.6%)和玻璃体炎(范围 0%至 14.5%;平均值±SD,5.6±4.7%)。

结论

对 BI-KPro 使用的已发表文章的综述表明,该装置可改善无法通过使用人尸体角膜移植技术进行角膜移植的严重角膜混浊的视力。随着随访的继续,可能会出现许多严重的前节和后节并发症,这使得患者接受这种手术时需要持续密切观察。这些并发症包括感染、器械脱出和永久性视力丧失。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验